Nadine Jagerovic

Title: Nadine Jagerovic: Innovator in Medicinal Chemistry

Introduction

Nadine Jagerovic is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds for therapeutic applications. With a total of 5 patents to her name, her work focuses on innovative solutions for diseases associated with specific receptors in the human body.

Latest Patents

Among her latest patents, Jagerovic has developed pyrazolylbenzene-1,3-diols for diseases associated with the G protein-coupled receptor 18. This invention relates to the use of these compounds as cannabidiol derivatives for the treatment and prevention of disorders linked to GPR18 and TRPV1 receptors. Additionally, she has created selective modulators of the GPR55 receptor through chromenopyrazole derivatives. These compounds are designed to treat various diseases, including diabetes, Parkinson's disease, and several types of cancer.

Career Highlights

Throughout her career, Nadine Jagerovic has worked with notable organizations such as Laboratorios del Dr. Esteve S.A. and the Consejo Superior de Investigaciones Científicas. Her research has significantly advanced the understanding of cannabinoid receptors and their potential therapeutic uses.

Collaborations

Jagerovic has collaborated with esteemed colleagues, including Maria Pilar Goya-Laza and Alberto Dordal Zueras. These partnerships have fostered a collaborative environment that enhances the innovation process in her research endeavors.

Conclusion

Nadine Jagerovic stands out as a leading inventor in the field of medicinal chemistry, with her innovative patents paving the way for new treatments for various diseases. Her contributions continue to impact the scientific community and improve patient outcomes.